Finance News – Cvs
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Cryptocurrency
Investors
Crypto assets
Markets
Blockchain
Ethereum
Investment
Sec
Stocks
Etf
Trade
Eth
Stablecoin
China
Shares
Stock
Coinbase
Earnings
Usd
Trade war
Price
Xrp
Economy
Revenue
Nasdaq
Trade deal
Solana
Token
Wall street
Inflation
Digital assets
Gold
Federal reserve
Trading
Interest rates
S&p 500
Ipo
Stock market
Profit
Binance
Stablecoins
Company
Defi
Bnb
Treasury
Mining
Support levels
Wp hg
Silk road
U.s. patent and trademark office
Metallurgical results
Atw
Nintendo switch 2
Drinking water inspectorate
On-chain applications
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0
px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400
text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Financial Post Top Stories
- Financial Times
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- The Block
- The Guardian – Business
CNBC Business • May 01, 2025
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS has raised its full-year earnings forecast to between $6 and $6.20 per share due to positive developments in its insurance sector, surpassing previous expectations.
Read Full Article →
CNBC Business • May 01, 2025
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, improving accessibility for patients on its drug plans and potentially increasing the treatment's market presence...
Read Full Article →